Therapeutic effect of adalimumab in the treatment of intestinal Behçet's disease in children
ObjectiveIntestinal Behçet's disease is a rare but severe manifestation of Behçet's disease, particularly in pediatric populations. Currently, there is no cure for intestinal Behçet's disease, and the goal of treatment is to control acute episodes and reduce inflammation. Adalimumab,...
Saved in:
| Main Authors: | Tianjiao Gao, Xiaoxia Ren, Yanan Han, Fengfan Wang, Bianhua Liu, Ying Fang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1619065/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01) -
Granuloma annulare treated with certolizumab following the development of antidrug antibodies to adalimumab
by: Ayelet I. Rubenstein, BA, et al.
Published: (2025-07-01) -
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01) -
Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation
by: Chunbo Zhang, et al.
Published: (2025-01-01) -
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study
by: Fanny Alcira Reyes Neira, et al.
Published: (2025-02-01)